Skip Navigation

European Journal of Heart Failure 2001 3(4):491-494; doi:10.1016/S1388-9842(01)00175-1
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thackray, S.
Right arrow Articles by Cleland, J. G.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thackray, S.
Right arrow Articles by Cleland, J. G.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2001 European Society of Cardiology

Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF

Simon Thackray, Alison Coletta, Peter Jones, Anita Dunn, Andrew L. Clark and John G.F. Cleland*

Department of Academic Cardiology, Castle Hill Hospital Cottingham Kingston-upon-Hull, Cottingham HU16 5JQ, UK

* Corresponding author. Tel.: +44-1482-624087; fax: +44-1482-624085. E-mail address: g.m.porter{at}hull.ac.uk (J.G. Cleland).


   Abstract

This article continues a series of reports summarising recent research developments pertinent to the topic of heart failure. This is a summary of presentations made at Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. Clinical studies of particular interest to people caring for patients with heart failure include CONTAK-CD, CHRISTMAS and further updates on OPTIME-CHF. A brief review of the current status of cardiac resynchronisation therapy is included.

Key Words: Heart failure • Cardiology • CONTAK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
R E Lane, J Mayet, N S Peters, D W Davies, and A W C Chow
Comparison of temporary bifocal right ventricular pacing and biventricular pacing for heart failure: evaluation by tissue Doppler imaging
Heart, January 1, 2008; 94(1): 53 - 58.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G.-P. Diller, D. Okonko, A. Uebing, S. Y. Ho, and M. A. Gatzoulis
Cardiac resynchronization therapy for adult congenital heart disease patients with a systemic right ventricle: analysis of feasibility and review of early experience.
Europace, April 1, 2006; 8(4): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D J Fox, A P Fitzpatrick, and N C Davidson
Optimisation of cardiac resynchronisation therapy: addressing the problem of "non-responders"
Heart, August 1, 2005; 91(8): 1000 - 1002.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. T. Abraham and D. L. Hayes
Cardiac Resynchronization Therapy for Heart Failure
Circulation, November 25, 2003; 108(21): 2596 - 2603.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. G.F. Cleland, J. Ghosh, N. K. Khan, S. Ghio, L. Tavazzi, and G. Kaye
Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony?
Eur. Heart J., March 1, 2003; 24(5): 384 - 390.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Thackray, J. Easthaugh, N. Freemantle, and J. G.F. Cleland
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure--a meta-regression analysis
Eur J Heart Fail, August 1, 2002; 4(4): 515 - 529.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
D. Gras, C. Leclercq, A. S.L. Tang, C. Bucknall, H. O. Luttikhuis, and A. Kirstein-Pedersen
Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study
Eur J Heart Fail, June 1, 2002; 4(3): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Coletta, S. Thackray, N. Nikitin, and J. G.F. Cleland
Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL
Eur J Heart Fail, June 1, 2002; 4(3): 381 - 388.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.